Acute Myocardial Infarction in Cancer Patients
Status
Conditions
Treatments
Details and patient eligibility
About
Using national health insurance service database, current study aim to evaluate the risk and prognosis of acute myocardial infarction in cancer patients and to find the optimal treatment strategy for acute myocardial infarction that can improve long-term prognosis.
Full description
This study will be conducted using Korean National Health Insurance Service database. Patients who were diagnosed with cancer from 2002 to 2021 will be included in the study. Using the selected patients, current study will analyze the incidence and prognosis of acute myocardial infarction in cancer patients and the prognosis according to the treatment method for acute myocardial infarction will be compared. Primary outcome will be all-cause death. Secondary outcomes will be myocardial infarction, revascularization, hospitalization for heart failure, stroke, and clinically relevant bleeding.
Enrollment
Sex
Volunteers
Inclusion criteria
- Patients diagnosed with cancer between 2002 and 2021
- Patients who were diagnosed with acute myocardial infarction after cancer diagnosis
Exclusion criteria
- Patients who died during period of cancer diagnosis
Trial design
4,500,000 participants in 2 patient groups
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal